FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Panel to Discuss Abbotts TriClip Data

FDA convenes a 2/13 advisory committee meeting to discuss the clinical significance of Abbott Medicals TRILUMINATE pivotal trial that evaluated the co...

latest-news-card-1
Medical Devices

Proscia Digital Pathology Software Cleared

FDA clears a Proscia 510(k) for its Concentriq AP-Dx, a diagnostic software for pathologists for viewing, interpreting, and managing whole slide image...

latest-news-card-1
Biologics

FDA Lifts Hold on Hemogenyx CAR-T Therapy

FDA removes a clinical hold against Hemogenyx Pharmaceuticals IND for the companys chimeric antigen receptor T-cells therapy for treating acute myeloi...

latest-news-card-1
Human Drugs

Takedas Eohilia OKd for Eosinophilic Esophagitis

FDA approves a Takeda NDA for Eohilia (budesonide oral suspension), indicated for treating eosinophilic esophagitis.

latest-news-card-1
Human Drugs

Orphan Status for Polycythemia Vera Drug

FDA grants Disc Medicine an orphan drug designation for DISC-3405 for treating patients with polycythemia vera.

latest-news-card-1
Medical Devices

Samsung Wins De Novo for Sleep Apnea Watch, Phone

FDA grants Samsung Electronics a de novo authorization for a sleep apnea feature using a compatible Samsung Galaxy Watch and phone.

latest-news-card-1
Human Drugs

New Fresenius Hemodialysis Device Cleared

FDA clears a Fresenius Medical Care 510(k) for its 5008X Hemodialysis High-Volume System.

latest-news-card-1
Human Drugs

Rule on Master Files and Biologics

FDA issues a final rule to amend its regulations about the use of master files for biological products.

latest-news-card-1
Human Drugs

FDA/Philips Dispute on CPAP Safety Revealed: Report

A new ProPublica/Pittsburgh Post-Gazette article reveals that in the early days of the 2021 recalls by Philips Respironics of its troubled CPAP breath...

latest-news-card-1
Federal Register

FDA Debars Brendon Gagne for 5 Years

Federal Register notice: FDA issues an order debarring Brendon Gagne for five years from importing or offering for import any drug into the U.S.